ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2023

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2023
NameSharesValueWeighting ↓
BlackRock Inc. 2,037,550$1,461,7390.00%
Mariner, LLC 20,000$140.00%
Bank of New York Mellon Corp 54,485$39,0880.00%
GHP Investment Advisors, Inc. 200$1440.00%
Citadel Advisors 20,800$14,9220.00%
Citadel Advisors 4,221$3,0280.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 55,400$39,8880.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 83,207$59,6920.00%
VANGUARD GROUP INC 4,143,131$2,972,2820.00%
Tower Research Capital LLC (TRC) 15,281$100.00%
Allworth Financial LP 20$150.00%
ROYAL BANK OF CANADA 1,712$1,0000.00%
VICTORY CAPITAL MANAGEMENT INC 10,166$7,2930.00%
JANE STREET GROUP, LLC 92,643$66,4620.00%
Cubist Systematic Strategies, LLC 31,506$22,6020.00%
UBS Group AG 14,979$10,7400.00%
JPMORGAN CHASE & CO 1,210,212$868,0000.00%
BNP PARIBAS FINANCIAL MARKETS 22$160.00%
External links

This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q1 2023. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.